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Abstract
We present a novel extended-focus optical coherence microscope (OCM)
attaining 0.7 µm axial and 0.4 µm lateral resolution maintained over a
depth of 40 µm, while preserving the advantages of Fourier domain OCM.
Our method uses an ultra-broad spectrum from a super-continuum laser
source. As the spectrum spans from near-infrared to visible wavelengths
(240 nm in bandwidth), we call the method visOCM. The combination
of such a broad spectrum with a high-NA objective creates an almost
isotropic 3D submicron resolution. We analyze the imaging performance
of visOCM on microbead samples and demonstrate its image quality on
cell cultures and ex-vivo mouse brain tissue.
1 Introduction
Over the past decades, optical microscopy has allowed investigating biological
systems at high spatial and temporal resolution. Confocal fluorescence mi-
croscopy [1] and light-sheet microscopy[2], through their capabilities in three-
dimensional imaging, have become the mainstay for cellular and subcellular
imaging. Nevertheless, while fluorescence provides molecular specificity, the in-
fluence of these agents on cellular processes is ambiguous as they might interfere
with the functioning of the cell. These effects combined with photobleaching
ultimately hinder the possibility to perform long-term imaging.
In such studies, label-free microscopy offers an interesting alternative as it
can provide wide-field images at high acquisition rates without using exoge-
nous agents. Moreover, the absence of labels facilitates the sample preparation.
Recent advances in phase microscopy [3] and ptychography [4] have allowed per-
forming three-dimensional imaging of cellular cultures or embryos but remain
limited to thin single layer structures.
Optical coherence tomography (OCT) is an interferometric imaging tech-
nique sensitive to refractive index contrast in the sample [5]. In OCT, the axial
resolution is defined by the width of the illumination spectrum and an entire
depth profile can be obtained from a single recording of the output spectrum.
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As such, only a two-dimensional scan is required to obtain a three-dimensional
image.
Optical coherence microscopy (OCM), the microscopy analogue to OCT,
uses high-NA objectives to obtain a higher lateral resolution. In standard OCM
systems, however, the axial field of view is dictated by the Rayleigh range and
thus decreases quadratically (∝ 1/ NA2) with the improvement in lateral res-
olution (∝ 1/ NA). This compromise can be circumvented by engineering an
extended-focus illumination through the use of so-called diffraction-less beams
such as Bessel beams [6].
In order to maintain a good collection efficiency of the scattered light signal, a
Gaussian detection mode is used. Therefore, separate illumination and detection
modes are required: a Bessel illumination mode and a Gaussian detection mode.
This split between modes can further be exploited to filter specular reflections
and obtain a dark-field OCM system [7]. The dark-field property is particularly
important when investigating weakly scattering structures, such as cell samples,
as it suppresses light reflected from the sample support which would otherwise
strongly reduce the usable dynamic range of the detector. As such, all available
dynamic range can be devoted to the desired, but weak, scattered light signal.
In this paper, we present visible spectrum optical coherence microscopy (vi-
sOCM). The system builds upon our previous dark-field OCM design, and im-
proves its imaging capabilities for sub-cellular structures by using a large band-
width illumination spectrum spanning visible to near-infrared wavelengths and
a high-NA objective. The resulting system possesses an almost isotropic sub-
micron resolution (0.4 µm laterally and 0.7 µm axially) maintained over a large
depth of field (¿40 µm). Hence visOCM extends the capabilities of our previ-
ous non-imaging visible light optical coherence correlation spectroscopy (OCCS)
system and is optimized three-dimensional cellular tomography [8]. We present
a strategy for dispersion compensation and demonstrate the system’s 3D resolu-
tion on microbead samples. We demonstrate visOCM’s image quality and con-
trast on living cell cultures as well as fixed brain slices of healthy and alzheimeric
mice.
Besides imaging the structure of a sample at a given time-point, there is
also much interest in monitoring intracellular dynamics to understanding cell
function. As such, several optical microscopy techniques have been developed
to analyse cell trafficking and intracellular motility[9, 10, 11]. Recently, OCT
methods developed to obtain qualitative and quantitative information on vas-
cular function have been used to reveal sub-cellular compartments and quantify
their activity [12, 13]. Being a Fourier-domain method, visOCM is capable of
rapidly acquiring tomograms, and therefore these dynamic signal imaging meth-
ods can be applied to visOCM as well. We demonstrate dynamic signal imaging
with visOCM on living cells.
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2 Materials and Methods
2.1 Optical Setup
As illustrated in Figure 1, the optical setup is based on a Mach-Zehnder inter-
ferometer, allowing for a separation of the illumination and detection modes,
necessary to obtain the desired Bessel-Gauss configuration. The output of a
supercontinuum laser (Koheras SuperK Extreme, NKT Photonics) is first fil-
tered through three broadband dielectric mirrors (BB1-EO2, Thorlabs) to reject
the source’s strong infrared emission. Then, the light is split by a polarizing
beam-splitter (PBS251, Thorlabs), and injected in the interferometer using a
single-mode fiber (P3-460B-FC-2, Thorlabs). As shown in Figure 3(a), the
spectrum in the interferometer is centred at 647 nm and has a 246 nm band-
width. After collimation, the light passes through a polarizer and then a first
beamsplitter (BS1) splits the light into the reference and illumination paths,
where an axicon lens (Asphericon, apex angle 176◦) generates a Bessel beam.
The beam is then Fourier filtered in a telescope to remove stray light originat-
ing from the axicon’s tip, after which it is steered to the scan-unit, and focused
on the sample by a 40x high NA objective (Olympus, effective NA = 0.76).
The back-scattered light is collected by the objective, de-scanned by the scan-
unit and directed to the detection arm through a second beam splitter (BS2)
where it is coupled to a custom-made spectrometer with a single-mode fiber
(P3-460B-FC-2, Thorlabs). The spectrometer is comprised of a transmission
grating (600 lines/mm, Wasatch Photonics) and a fast line-scan camera (Basler
spL2048-140km). Dispersion matching between both interferometer arms was
performed by adding a combination of prism pairs in the reference arm. The
detailed dispersion matching strategy is presented in 2.2.
To obtain a dark-field configuration, the specular reflection was suppressed
by spatially filtering the reflected Bessel ring through a mask in the detection
arm (mask 2) and by properly filtering the stray light from the tip of the axicon
lens (mask 1).
2.2 Dispersion compensation strategies
The use of a broad illumination spectrum in visOCM, renders dispersion match-
ing more challenging, particularly in the visible spectrum where the relationship
between the refractive index and the wavelength becomes increasingly non-linear
at shorter wavelengths. Here we opted for a physical dispersion compensation
scheme where we first estimated the dispersion caused by the illumination and
sample arms prior to constructing the optical system. This allowed us to calcu-
late the best composition of prisms to place in the reference arm (Figure 2(a)).
In a second step, during the construction of the setup, we developed a real-time
interface in LabView to display the amount of residual dispersion and used a
motorized stage to finely adjust the thickness of the different glasses (Figure
2(b-c)).
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Figure 1: Schematic of the extended-focus OCM using a broad spectrum in the
visible wavelength range and a high NA objective for high axial and lateral res-
olution. By combining a Bessel illumination, generated by an axicon lens, and a
Gaussian detection, a dark-field extended-focus system can be obtained. P: Po-
larizer, BBDM: Broadband dielectric mirror, BS: Beamsplitter, PBS: Polarizing
beamsplitter.
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2.2.1 Estimation of the dispersion in the optical system
Prior to constructing the optical system, we first estimated the thickness of
each glass type present in the different arms of the interferometer. The glass
type and respective thickness of each optical element (lenses and beamsplitters)
were obtained from the data-sheets provided with each element by Thorlabs.
The objective was not modelled in this initial assessment as its composition is
unavailable. As depicted in Figure 2(a) and described in Equation 1, we then
proceeded to estimate the k -dependent optical path length of each part of the
system (sample arm, illumination arm and reference arm) by using the thickness
of each glass and their respective dispersion curves (Sellmeier coefficients from
the SCHOTT database available on https://www.refractiveindex.info) to obtain
the optical path difference (OPD).
OPD(k) =
[
nsample,SF5(k), . . . , nsample,UV FS(k)
]  dsample,SF5...
dsample,UV FS
 . . .
+
[
nill,SF5(k), . . . , nill,UV FS(k)
]  dill,SF5...
dill,UV FS
 . . .
− [nref,SF5(k), . . . , nref,UV FS(k)]
 dref,SF5...
dref,UV FS
 (1)
The obtained OPD was then fit to a set of dispersion curves through a
multivariate linear regression to find the thickness of the set of glasses to best
balance the dispersion. As described in Equation 2, the multivariate linear
regression tries to model the OPD as the sum of the refractive indexes (in
function of k) of each glass multiplied by their respective thicknesses and an
error term (k). By performing this analysis, we can therefore retrieve the
thicknesses of each glass required to compensate the OPD of the optical system.
An initial analysis of several sets of glasses revealed that combining BK7 and
SF10 allowed fully balancing the dispersion of the system.
OPD(k) =
[
nBK7(k), nSF10(k)
] [dBK7
dSF10
]
+ (k) (2)
2.2.2 Fine matching of the dispersion
During the construction and alignment of the system, the dispersion was finely
balanced by calculating the residual dispersion in the system and by adjusting
the thickness of each individual glass through a pair of motorized mechanical
stages. The residual dispersion was measured by placing a sample consisting
of a cover glass and a mirror. Then the interferogram’s phase was calculated
5
by Hilbert transformation [14], and a linear fit was subtracted (Figure 2(c)).
If the dispersion is perfectly balanced between the arms of the interferometer
then the residual dispersion curve should be null throughout the spectrum. The
motorized mechanical stages, as depicted in Figure 2(b), consists of a stepper
motor operating a cogwheel mechanism. The mechanism allows varying the
angle between two glass windows, in order to fine-tune the amount of that glass
type in the reference arm. Moreover, as the system is symmetrical, changes
in the beam’s transverse position caused by the passage of the light through
the first window are compensated by the second window. As such, varying the
amount of glass causes minimal changes in the alignment of the optical system.
The combination of these two effects (fine-tuning and minimal misalignment)
facilitates the dispersion compensation procedure. By observing the residual
dispersion and iteratively changing the thickness of each glass we could balance
the dispersion of the two arms of the microscope. We used SF6 windows, instead
of SF10, for dispersion fine tuning.
2.3 Image acquisition and processing
All images were acquired at a 20 kHz A-scan rate (with an integration time of
43 µs) and with a power varying from 1.5 mW to 3 mW in the back-focal plane
of the objective. With the exception of the dynamic signal imaging protocol
(presented in 3.4), the size of each image was 512 × 512 × 2048 pixels (x,y and k
respectively). Large field-of-views were obtained by stitching several tomograms
(each having a lateral field-of-view of either 60 µm × 60 µm, or 120 µm × 120
µm) with a 30% overlap between each tile of the mosaic in both directions.
Any tilt (angle with respect to the optical axis), was corrected on both axes
(x-z and y-z ) prior to stitching. The tomogram processing, tilt-correction and
stitching were performed through a custom-coded MATLAB graphical interface.
The tomograms presented in Figures 4–7 are displayed with the intensity in
logarithmic scale for visualisation purposes. The tomograms were convolved
with a 3D Gaussian kernel (σx,y = 0.187 µm, σz = 0.22 µm) and were then
resized to obtain an isotropic sampling using ImageJ.
2.4 Sample preparation
2.4.1 Mice brain slices
All experiments were carried out in accordance to the Swiss legislation on animal
experimentation (LPA and OPAn). The protocols (VD 3056 and VD3058) were
approved by the cantonal veterinary authority of the canton de Vaud, Switzer-
land (SCAV, De´partement de la se´curite´ et de l’environnement, Service de la
consommation et des affaires ve´te´rinaires) based on the recommendations issued
by the regional ethical committee (i.e. the State Committee for animal experi-
ments of canton de Vaud) and are in-line with the 3Rs and follow the ARRIVE
guidelines. Brain slices were obtained by perfusing transcardially B6SJL/f1
mice with PBS followed by 10% Formalin (HT501128, Sigma-Aldrich). The
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Figure 2: Dispersion compensation strategies: (a) Prior to aligning the optical
setup, a first estimation of the dispersion mismatch in the system is performed
by modelling the optical path length of the different arms of the interferome-
ter. The thicknesses and dispersion curves of the different glasses are used to
model the OPD between the arms of the system. The OPD is then fit with a
multivariate regression using the dispersion curves of SF10 and BK7 as set of
regressors to obtain the respective thicknesses to fully balance the dispersion in
the interferometer. (b) In order to match the dispersion, a compensation unit
was devised allowing a fine control of the thickness of the glass. A mechanism
comprising a stepper motor and cogwheels allows changing the angle of a pair
of glass windows to vary the length of glass traversed by light. (c) During the
alignment, the dispersion was matched by observing and minimizing the residual
dispersion present in the system, obtained by a simple set of processing steps:
The interferogram first undergoes a λ-k mapping step from which the phase is
then extracted by a Hilbert transform. The linear component of this phase is
then extracted and removed to reveal the residual dispersion.
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mice were injected subcutaneously with Temgesic prior to the perfusion with
heparinized PBS. The extracted brains were then left in 4% PFA overnight,
and then placed in a solution of 30% glucose. Finally, the brains were cut into
slices using a microtome at a thickness of ∼30 µm and placed on a glass cover-
slide. Brain slices from 5xFAD mice, a mice model of amyloid pathology, were
obtained using the same protocol. The amyloid plaques were stained using a
solution of Methoxy-X04 in DMSO, which was administered through two I.P.
injections 24h and 2h before the perfusion, as described by Ja¨rhling et al. [15].
2.4.2 Macrophages preparation
In addition to mice brain slice imaging, we imaged live murine macrophages
(cell line RAW 264.7) with the visOCM platform. The RAW 264.7 cells were
cultured in an incubator at 37◦C and 5% CO2 using DMEM high glucose with
pyruvate (4.5 g l-1 glucose, Roti®-CELL DMEM, Roth) supplemented with
10% fetal bovine serum and 1×penicillin-streptomycin (both gibco®, Thermo
Fisher Scientific). Prior to imaging (1-2 days), the cells were seeded in Fluo-
roDish Sterile Culture Dishes (35 mm, World Precision Instruments).
3 Results
3.1 System Characterization
The system’s lateral resolution was characterized by imaging a solution of nanopar-
ticles of 30 nm in diameter embedded in a slab of PDMS. The small size of these
particles allowed interrogating the point-spread function (PSF) of the optical
system. The depth-dependence of the lateral resolution was assessed by isolating
and averaging multiple (∼ 10) measurements of the PSF at 7 different depths.
The lateral profile of the measured PSF at each depth was then extracted, and
the position of the first zero served as a measure of the lateral resolution. As
shown in Figure 3(c) the width of the central lobe is maintained at 400 nm over
40 µm.
The axial resolution of the system was measured by imaging a mirror placed
on a glass coverslip in the sample arm. The reference power was adjusted to
obtain maximum visibility of the interference pattern. The axial PSF, measured
as mentioned previously, is plotted in Figure 3(b) and has a FWHM of 0.92 µm
in air, corresponding to a width of 0.69 µm in water.
3.2 Brain slice imaging
The imaging performance of visOCM was first demonstrated by imaging cor-
tical structures in fixed mice brain slices (∼30 µm thick) of both healthy and
alzheimeric mice.
The lateral and axial resolution and contrast offered by the visible spectrum
allows resolving several different entities present in the brain such as myelinated
fibers, vascular structures, cell bodies and amyloid plaques.
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Figure 3: Characterization of the visOCM system: (a) Illumination spectrum
spanning from the visible to the near-infrared range, centred at 647 nm and 246
nm wide. (b)The ultra-broad spectrum leads to a submicrometric optical sec-
tioning capability. (c) Plots and heatmaps (in linear scale) displaying the lateral
PSF along the depth of focus of the objective, illustrating that the diameter of
the central lobe is maintained at ∼400 nm over 40 µm in depth. Scalebar: 500
nm
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Figure 4: ex-vivo visOCM imaging of the PTLp cortex in a B6SJL/f1 mouse
brain slice. (a) A transmission image of the entire mouse hemisphere was first
acquired to locate the desired area (green rectangle), which was then imaged
with visOCM (b). The mosaic of part of the PTLp cortex, acquired with vi-
sOCM, reveals a variety of cortical structures, such as fibers, cell bodies and
vascular entities (en-face view). In the mosaic, mainly two types of cells can be
visualized, large cells as shown in (c) and smaller darker cells as pointed by ar-
rowheads in (d). The orthogonal views in (c–d) highlight the three-dimensional
repartition of these cell types within the depth of the slice. Capillary vessels can
be discriminated from the tissue as either dark or bright structures as shown
in (e) and (f) respectively. These different contrasts are further revealed in the
orthogonal slices accompanying the close-ups, where one can trace the path of
the hollow dark lumen or the bright vessel border, pointed by the arrowheads.
En-face images at different depths show that visOCM can perform imaging over
¿20 µm (g). Scalebars: 150 µm (b), 50 µm for the en-face and 20 µm for the
orthogonal views (c–g).
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Figure 5: ex-vivo visOCM imaging of the RSPd cortex in a B6SJL/f1 mouse
brain slice. (a) A transmission image of the entire half hemisphere was per-
formed to locate part of the RSPd cortex (blue rectangle). A mosaic of the
area of interest was then obtained with visOCM (b), where one can appreciate
the presence of fibers, vessels and cells. A large penetrating vessel (c) can be
observed through the difference in contrast between its hollow lumen and the
back-scattering of the surrounding tissue. Examples of bifurcations and poten-
tial clogging of the vessel are pointed by arrowheads in the orthogonal view.
Fibers appear as thin oriented bright structures and are present in the cortex
and in the corpus callosum (d). Finally, sub-cellular features can also be ob-
served as darker spots within the cell bodies, as shown in (e–h) and pointed by
arrowheads in (e). Scalebars: 150 µm in (b), 50 µm in the en-face view of (c–d),
20 µm in the orthogonal views of (c–d) and in the en-face view of (e), 10 µm in
the en-face and orthogonal views of (f–g).
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3.2.1 Myelin fibers
Similarly to previous studies performed with OCM at longer wavelengths [16,
17, 18, 19], myelin and neural fibers appear as bright linear structures through
their increased back-scattering. In Figures 4(a) and (c), fibers emerge from the
corpus callosum and the cingulum bundle and spread throughout the cortical
column. The corpus callosum, shown in Figure 5(d), contains a high density of
fibers and can be distinguished as a bright region with orientated stripes. The
cortex is characterized by a lower density of fibers with a higher variability in
their orientation.
3.2.2 Vascular structures
Vascular compartments, from large calibres (penetrating arterioles and ascend-
ing venules) to the smallest capillaries can be discriminated from the background
tissue as either hollow tubes (from the empty lumen) or as thin bright struc-
tures. Figure 5(c) shows the en-face and orthogonal slice of a large penetrating
vessel where one can distinguish the hollow lumen from the tissue and visualise
bifurcations along the propagation of the vessel. Additionally, the edges of the
vessel exhibit an increased signal, which could either be caused by a change in
the scattering properties of the vessel’s membrane or its surrounding tissue (for
example vascular smooth muscle). Smaller vessels, such as capillaries, can also
be observed in the tomograms and appear either as dark or bright structures
compared to the surrounding tissue. Figures 4(e) and (f) show both dark and
bright capillary structures and show that it is possible to trace their trajec-
tory regardless of their contrast. Similarly to the large vessel in 5(c), the dark
contrast is indicative of a lack of scatterers within the lumen of the capillary.
The bright contrast, on the other hand, could originate from scatterers filling
the vessel’s lumen (i.e. clogging during the perfusion procedure) or from the
different scattering properties of the vessel’s boundary.
3.2.3 Cell bodies
In addition to neuronal fibers and capillaries, visOCM imaging allows visualizing
different cell body types through their different contrast with respect to the
extracellular space. Figures 4(b) and 5(b) present mosaics covering parts of the
posterior parietal association areas (PTLp1) and the retrosplineal area (RSPd)
respectively, where one can observe two main cell body types with different
contrasts and shapes. As highlighted in Figure 4(d), some of the cells appear as
dark spherical shapes, due to a decreased back-scattering. The second type of
cells visible in Figure 4(c) have similar contrast than the extracellular space and
are larger. In addition to their different shapes and back-scattering properties,
the two cell types also appear to be present in different regions of the cortical
column: the darker and smaller cells are denser in the upper layers whereas
the larger cells seem more prominent in the deeper layers, closest to the corpus
callosum. Cells in the cornu ammonis area 1 (CA1), as shown in Figure 6(b), are
also characterized by a darker contrast, similar to the cells in the upmost layers
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of PTLp1. Additionally, one can notice in the RSPd brain slice the presence
of a small darker substructure within the body of certain cells. Figure 5(e–h)
displays a selection of these cells and their dark subcellular structure. Although
a more complete study is necessary to elucidate the nature of this feature, our
experience in live-cell imaging (results shown in Figure 7) has shown that a
similar contrast is present in what seems to be the nucleus. The orthogonal
views and tile (g) of Figure 4 show that the signal acquired with visOCM extends
throughout the depth of the tissue slice, although a loss in intensity and blurring
can be observed in the deeper layers.
3.2.4 Amyloid plaques
Previous work from our group has shown that amyloid plaques can be distin-
guished from cerebral tissue using xfOCM operating at 800 nm through their
increased scattering [16]. In continuation of this work, we imaged brain slices of
an alzheimeric mouse model with our novel visOCM system, with the expecta-
tion that the increased spatial resolution and different illumination wavelength
would shed light on the details of these aggregates. We therefore imaged a part
of the PTLp cortex and subcortical structures (CA1) of a 5xFAD mouse. As
shown in Figure 6(b) and similarly to the results in Figures 4(b) and 5(b), the
cortex is characterized by a high density of fibers and of cell bodies. The subcor-
tical region, below the corpus callosum, has a slightly lower intensity compared
to the cortex and presents a line of cells (CA1). Similarly to the results obtained
at 800 nm [16], the amyloid plaques manifest themselves as high intensity regions
with a darker core. The increased spatial resolution of the system reveals with
great detail the irregular shape of these aggregates, as shown in 6(c–d). The
plaques are, as expected, present in cortical and also subcortical regions [20],
where the slightly decreased intensity of the cerebral tissue provides a higher
contrast between the plaques and the background. The location of the plaques
was colocalized with fluorescence imaging of Methoxy-X04 using a commercial
widefield microscope (Axiovert 200M, Zeiss), a 20x / 0.5 NA objective and the
DAPI filter set (Excitation filter: 365 nm, dichroic mirror: 395 nm, Emission
filter: 445/50 nm). As shown in tiles (c–d) of Figure 6, the locations of the ag-
gregates in visOCM are in agreement with the location of the labelled structures
in the fluorescence image.
3.3 Cell imaging
In addition to the imaging of tissue structures, we performed imaging of live
macrophages in a cell culture. A mosaic of tomograms of these macrophages is
shown in Figure 7(a). The capabilities of the extended-focus can be appreciated
in the orthogonal views of the tomogram, where the signal extends sufficiently in
depth to reveal the three-dimensional organisation of the culture, with certain
cells lying on top of other cells. The strongly scattering cytoplasm of the cell
appears as a bright structure surrounding a darker subvolume, which most likely
corresponds to the cell nuclei. The increased lateral resolution of the system
13
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Figure 6: ex-vivo imaging of cortical and subcortical structures in a 5xFAD
mouse brain slice. (a) A transmission image shows the location of the area
where a visOCM image mosaic was obtained (b). The visOCM mosaic reveals
fibers, cells and amyloid plaques in both cortical and subcortical structures.
Close-ups of areas of interest containing amyloid plaques, in both cortical and
subcortical regions, are displayed with their en-face views and corresponding
fluorescence image (c–d). In the visOCM image, plaques can be seen as irregular
high intensity regions. Scalebars: 150 µm in (b), 50 µm in the en-face and 20
µm m in the orthogonal views of (c–d).
14
allows resolving the filopodia on certain cells.
3.4 Dynamic signal imaging
In a second step, we analysed the dynamic properties of the scattering signal
from living cells. In contrast to previous dynamic signal imaging techniques
using the autocorrelation function or the standard deviation of the OCT sig-
nal [12, 10, 13], we extracted the dynamic component of the back-scattering
through a point-wise subtraction of the complex OCM signal (Figure 7(b)), as
developed by Srinivasan et al. for OCT angiography [21]. A time-series of scat-
tering fluctuations per voxel was obtained by sampling each transverse position
(B-scan) 32 times with a timestep of Δt = 27 ms. Each timepoint was then
temporally high-pass filtered (through a point-wise complex subtraction) and
then averaged. A temporally averaged image was also obtained by averaging
the repeated acquisitions. The results of this operation are shown in Figure 7(c)
and Figure 7(d) showing the averaged and dynamic signals respectively. Inter-
estingly, in addition to the lower intensity of the cell nucleus already present in
the static imaging, the dynamic imaging further reveals details within the cell
body. As shown in Figure 7(d), darker regions are present within the nuclei of
the cells and brighter spots can be observed within the cytoplasm. Finally, the
interface between the nuclei and the cytoplasm appears as a fine dark structure
in certain cells. These differences are further revealed in Figure 7(e) and (f)
showing close-ups of a selected cell in the temporally averaged and dynamic
signal image respectively.
4 Conclusion
In this work, we presented a novel OCM system, called visOCM, combining
an extended-focus [6], a dark-field detection [7], a high-NA objective and an
ultra-broad illumination spanning from the visible to the near-infrared wave-
length range. As demonstrated here, the combination of these features provides
an almost isotropic submicron resolution, maintained over ¿ 40 µm in depth.
The capabilities of visOCM were demonstrated by imaging brain tissue slices
of healthy and alzheimeric mice and macrophages cell cultures. The imaging of
brain tissue with visOCM reveals several cortical structures as vessels, capillar-
ies and cells. Interestingly, these different structures exhibited a wide range of
contrasts, even within the same structure type. Capillaries could be observed as
both dark or bright hollow structures. Although one cannot discard changes in
tissue caused by the sample preparation (i.e. clotting and vessel collapsing due
to the perfusion), the bright contrast could emanate from the presence of tissue
bordering the vessels (such as smooth muscle cells or pericytes). Conversely, the
dark contrast arises from a lack of scatterers from the hollow lumen of the ves-
sel. Previous studies involving OCT and OCM imaging of brain tissue showed
that certain cells could be identified through their different contrast within the
cerebral tissue [12, 17, 19, 22]. Srinivasan et al. and Tamborski et al. observed
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Figure 7: visOCM imaging of murine macrophages. (a) A mosaic of
macrophages obtained with visOCM with its orthogonal views reveals the three-
dimensional organisation of cells in a culture. We further explored the capabil-
ities of visOCM by applying a protocol similar to OCT angiography (b). The
protocol entails imaging each lateral position along the slow axis 32 times (32 re-
peated B-scans per location). These 32 B-scans are either averaged or undergo
a point-wise complex subtraction to obtain an averaged image (c) or a view
of the dynamic components of the tomogram (d) respectively. The averaged
image is identical in contrast to (a), whereas the dynamic signal image further
reveals compartments within the cell, as either darker or brighter subregions (d)
Close-ups of a selected cell in (c) and (d) are shown in (e) and (f) respectively,
highlighting the differences in contrast between the averaged and dynamic im-
ages. Scalebars: 50 µm in the en-face view in (a), 20 µm in the orthogonal views
in (a) and in the en-face views of (c–d), 10 µm in the orthogonal views in (c–d)
and in the en-face views of (e–f), 5 µm in the orthogonal views in (e–f).
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that certain neuron types could be discriminated from the tissue by their dark
contrast using an OCM operating at 1300 nm and 800 nm respectively [17, 22].
By exploiting a higher lateral resolution and by shifting the illumination spec-
trum to the visible wavelength range, we show that this intrinsic contrast seems
to vary between cell types and thus could be used in the future to identify differ-
ent types of neurons and inter-neurons. Furthermore, the increased resolution
of the visOCM system reveals subcellular features, potentially the cell nuclei.
Future work will focus on elucidating the causes of these different contrasts
and attempt to discriminate and potentially classify the cells according to their
intrinsic scattering properties.
In a second step, we built upon a previous study performed at 800 nm by
imaging brain slices of alzheimeric mice models with our novel system [16].
Similarly to our aforementioned results, the plaques appear as bright irregular
structures in the tomograms obtained with visOCM. Although the exact nature
of this particular contrast remains unknown, the presence of metals (such as
Fe) in amyloid plaque cores, as described by Plascencia-Villa et al. [23], might
provide a first hint into the cause of this phenomenon. In fact, a previous
study from our group showed that the contrast of the Langerhans islets in
OCM images originated from the presence of Zn crystals [24]. Alternatively,
this contrast could also arise from polarization effects as the plaques have been
shown to have birefringent properties [25].
Finally, we demonstrated the performance of visOCM by imaging live-cells
in cultures. The extended-focus and high acquisition rates available with the
platform allows fast imaging of the three-dimensional structure of cell cultures.
The shift in illumination wavelength and increase in NA provides the resolution
necessary to identify thin structures such as filopodias and sufficient contrast
to visualize seemingly sub-cellular structures. Recent studies have highlighted
the importance of studying the dynamic properties of cellular back-scattering to
understand cellular function [26]. In this context, we explored the possibility to
perform dynamic imaging, as already performed in full field OCM [13], OCM [9]
and phase imaging [11], with our novel imaging platform to further discriminate
between subcellular compartments. We applied a protocol devised for OCT an-
giography [21] and show that a dynamic contrast can be obtained in a culture
of macrophages. Although more work is needed to identify the different regions
and the nature of the signals, one can appreciate the increased contrast pro-
vided by the protocol. Overall, the combination of the extended-focus, the high
isotropic resolution and high acquisition rates make visOCM an ideal platform
to monitor fast processes occurring at the subcellular level in cell cultures.
In addition to our demonstration of the capabilities of our novel visOCM sys-
tem, we have introduced a strategy for physical dispersion compensation. We
used a multivariate linear regression to model the OPD of the system prior to
alignment and present a processing pipeline and a hardware unit to finely mini-
mize the dispersion during the construction of the microscope. In this work, we
opted for a hardware dispersion compensation strategy, however numerical dis-
persion compensation techniques could also have been used and will be explored
in future work.
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Ultimately, visOCM offers label-free 3D imaging of tissue and cell struc-
tures but remains limited through its lack in specificity. Our results show that
it is possible to discriminate between structures in tissue and cells through
their individual back-scattering properties and potentially through their dy-
namic signatures (as revealed by our dynamic imaging). Nevertheless, these
contrast mechanisms are limited and do not always provide the desired molecu-
lar specificity. In such regards, the visOCM platform could be augmented with a
collinear fluorescence channel. This configuration would allow molecular-specific
fluorescent imaging to be complemented with visOCM imaging, providing in-
formation on the overall structural context of the organism under investigation.
In addition to fluorescence, the visible spectrum could be used to explore the
spectroscopic signatures of specific molecules. Spectroscopic OCT has shown
great promise in its ability to provide additional contrast mechanisms [27, 28].
Having an illumination in the visible wavelength range could be used to visual-
ize and discriminate between different endogeneous and/or exogenous contrast
agents within the imaged tissue or cells.
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